
Top stories




Marketing & MediaWhy relevance, not reach, is the real driver of email performance
Cristelle Snyman, Everlytic 14 hours


More news








Logistics & Transport
Hyundai Motor flags export disruptions as Middle East conflict hits shipping










Background
The optimum use of cytotoxic drugs for advanced colorectal cancer has not been defined. Our aim was to investigate whether combination treatment is better than sequential administration of the same drugs in patients with advanced colorectal cancer.
Read the rest of the article here. Please note: you must register in order to access articles on The Lancet site.